Regulation of angiotensin AT(1) receptor gene expression during cell growth of vascular smooth muscle cells

被引:11
|
作者
Nickenig, G [1 ]
Sachinidis, A [1 ]
Ko, Y [1 ]
Vetter, H [1 ]
机构
[1] UNIV BONN, MED POLIKLIN, D-53111 BONN, GERMANY
关键词
angiotensin AT(1) receptor; smooth muscle cell; vascular; cell growth; arteriosclerosis;
D O I
10.1016/0014-2999(95)00771-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cell proliferation influences the expression of numerous tissue-specific genes. The angiotensin AT(1) receptor is highly expressed on vascular smooth muscle cells where it mediates cell contraction upon activation with angiotensin II. Since vascular smooth muscle cell de-differentiation leads to differential expression of several genes, we investigated the effects of cell growth on angiotensin AT(1) receptor gene expression in vascular smooth muscle cells in culture. Northern hybridization analysis revealed a decrease of angiotensin AT(1) receptor mRNA levels to approximately 20% in proliferating cells in comparison to growth-arrested cells. There is a correlative loss of membrane-associated angiotensin AT(1) receptor protein in growing cells versus non-growing cells, as assessed by saturation radioligand binding assays. In addition, the BB-isoform of platelet-derived growth factor (PDGF-BB), which induces proliferation of quiescent vascular smooth muscle cells, causes a marked down-regulation of angiotensin AT(1) receptor mRNA. These data suggest that proliferation of vascular smooth muscle cells leads to reduced angiotensin AT(1) receptor gene expression. The mechanisms underlying this process and its physiological implications remain to be defined.
引用
收藏
页码:307 / 312
页数:6
相关论文
共 50 条
  • [41] Angiotensin-(1-7) inhibits vascular smooth muscle cell growth
    Freeman, EJ
    Chisolm, GM
    Ferrario, CM
    Tallant, EA
    HYPERTENSION, 1996, 28 (01) : 104 - 108
  • [42] Nox 4 regulation of vascular smooth muscle cell differentiation marker gene expression
    Deliri, Hamid
    McNamara, Coleen A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (01) : 12 - 14
  • [43] Downregulation of angiotensin II type 1 receptor by liver X receptor in vascular smooth muscle cells
    Imayama, Ikuyo
    Patton, Dan
    Inanaga, Keita
    Ohtsulbo, Hidelki
    Sunagawa, Kenji
    Chilki, Toshihiro
    HYPERTENSION, 2006, 48 (04) : E85 - E85
  • [44] Transcription suppression of thromboxane receptor gene expression by retinoids in vascular smooth muscle cells
    Uruno, A
    Sugawara, A
    Kudo, M
    Sato, M
    Sato, K
    Ito, S
    Takeuchi, K
    HYPERTENSION RESEARCH, 2003, 26 (10) : 815 - 821
  • [45] Telmisartan and insulin affect angiotensin II type 1 and type 2 receptor expression in vascular smooth muscle and vascular endothelial cells
    Nyby, Michael D.
    Douglas, Kyle
    Albedi, Karolin
    Makino, Hirofumi
    Tuck, Michael L.
    HYPERTENSION, 2006, 48 (04) : E89 - E89
  • [46] Telmisartan and insulin affect angiotensin II type 1 and type 2 receptor expression in vascular smooth muscle and vascular endothelial cells
    Tuck, Michael L.
    Nyby, Michael D.
    Douglas, Kyle
    Abedi, Karolin
    Makino, Hirofumi
    JOURNAL OF HYPERTENSION, 2006, 24 : 301 - 301
  • [47] Transforming growth factor β1, induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells
    Di Febbo, C
    Baccante, G
    Reale, M
    Castellani, ML
    Angelini, A
    Cuccurullo, F
    Porreca, E
    ATHEROSCLEROSIS, 1998, 136 (02) : 377 - 382
  • [48] ANGIOTENSIN-II REGULATION OF AT1 AND ALPHA(2A)-ADRENERGIC RECEPTOR EXPRESSION IN VASCULAR SMOOTH-MUSCLE
    ANDERSON, KM
    FASEB JOURNAL, 1993, 7 (04): : A877 - A877
  • [49] P2Y receptor regulation of PAI-1 expression in vascular smooth muscle cells
    Bouchie, JL
    Chen, HC
    Carney, R
    Bagot, JC
    Wilden, PA
    Feener, EP
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (03) : 866 - 873
  • [50] Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells
    Clark, MA
    Diz, DI
    Tallant, EA
    HYPERTENSION, 2001, 37 (04) : 1141 - 1146